| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |